🇺🇸 FDA
Pipeline program

IOV-2001

IOV-CLL-01

Phase 1 mab completed

Quick answer

IOV-2001 for Chronic Lymphocytic Leukemia is a Phase 1 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Chronic Lymphocytic Leukemia
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials